首页> 外文会议>Colloidal nanocrystals for biomedical applications VII >Cell as a factory for humanized encapsulation
【24h】

Cell as a factory for humanized encapsulation

机译:Cell作为人性化封装的工厂

获取原文
获取原文并翻译 | 示例

摘要

Variety efforts are being made to develop colloidal based drug delivery systems (DDSs), which encapsulate cytotoxic drug in a vehicle and release them in a controlled manner. However, the synthetic carriers developed thus far are hampered by rapidly clearance in the body, for example by phagocytes, possibly due to the non-natural surface characteristics in terms of chemistry, morphology, and mechanics. To circumvent this important challenge, we have exploited living mammalian cells as factories to encapsulate drugs in "natural vesicles". These natural vesicles are termed cell membrane capsules (CMCs), because they maintain the major membrane structure and functions as well as cytosolic proteins of the parental cells. We demonstrate that CMCs act as unique delivery vehicles, in which encapsulated substances can be processed stepwise by cellular enzymes and then be selectively released through protein channels built-in the membrane, in a controlled and sustained manner. The preliminary study investigating the macrophage response to CMCs indicated the potential of CMCs to avoid attack by the immune system.
机译:人们正在进行各种努力来开发基于胶体的药物递送系统(DDS),该系统将细胞毒性药物包裹在载体中并以受控方式释放它们。然而,迄今为止发展出的合成载体受到体内快速清除(例如吞噬细胞)的阻碍,这可能是由于化学,形态和力学上的非天然表面特性所致。为了规避这一重要挑战,我们利用哺乳动物活细胞作为工厂将药物封装在“天然囊泡”中。这些天然囊泡被称为细胞膜胶囊(CMC),因为它们维持主要的膜结构和功能以及亲代细胞的胞质蛋白。我们证明,CMCs充当独特的传递媒介,其中封装的物质可以被细胞酶逐步处理,然后通过膜内建的蛋白质通道以受控和持续的方式选择性释放。初步研究调查了巨噬细胞对CMC的反应,表明CMC避免免疫系统攻击的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号